New Therapy for Essential Tremor | Cala Health

This educational event will discuss essential tremor, the current treatments available for essential tremor, and a new treatment option, Cala Trio therapy. Presenters will share how Cala Trio therapy works to reduce hand tremors. To learn more about the first non-invasive targeted hand tremor therapy visit CalaTrio.com
About Cala Health
Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company’s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, and its vertically integrated commercial model is reshaping the delivery of prescription therapies. Cala Health’s lead product, Cala Trio™ is the only non-invasive prescription therapy for essential tremor. New therapies are under development in neurology, cardiology and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
About Cala Trio
Cala Trio is the first non-invasive targeted therapy that reduces hand tremors for adults living with Essential Tremor (ET). Prescription therapy is a simple, wrist-worn device that is calibrated to treat a patient’s unique tremor symptoms. When activated, Cala Trio gently stimulates the nerves in the wrist to disrupt the tremulous activity in the brain, without the need for invasive brain surgery or medication. The easy-to-use and effective Cala Trio can be prescribed through an in-person consultation or telemedicine appointment. Therapy is conveniently delivered to the patient’s home, and Cala Health educates patients based on how they learn-phone, video, user portal. Currently, the therapy is only available in the United States. To learn more visit CalaTrio.com
Stay Connected!
Facebook, Instagram, Twitter: @CalaHealth
LinkedIn: @Cala-Health-Inc
Websites: CalaHealth.com & CalaTrio.com